Finance
Results: 3037-3048 of 44055

MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026

ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds









